1. Pawankar R. Nasal polyposis: an update: editorial review. Curr Opin Allergy Clin Immunol. 2003; 2. 3(1):1–6. PMID:
12582307.
2. Pawliczak R, Lewandowska-Polak A, Kowalski ML. Pathogenesis of nasal polyps: an update. Curr Allergy Asthma Rep. 2005; 11. 5(6):463–471. PMID:
16216171.
Article
3. Wang QP, Escudier E, Roudot-Thoraval F, Abd-Al Samad I, Peynegre R, Coste A. Myofibroblast accumulation induced by transforming growth factor-beta is involved in the pathogenesis of nasal polyps. Laryngoscope. 1997; 7. 107(7):926–931. PMID:
9217133.
4. Levi-Schaffer F, Garbuzenko E, Rubin A, Reich R, Pickholz D, Gillery P, et al. Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta). Proc Natl Acad Sci U S A. 1999; 8. 96(17):9660–9665. PMID:
10449750.
5. Bradley DT, Kountakis SE. Role of interleukins and transforming growth factor-beta in chronic rhinosinusitis and nasal polyposis. Laryngoscope. 2005; 4. 115(4):684–686. PMID:
15805881.
6. Little SC, Early SB, Woodard CR, Shonka DC Jr, Han JK, Borish L, et al. Dual action of TGF-beta1 on nasal-polyp derived fibroblasts. Laryngoscope. 2008; 2. 118(2):320–324. PMID:
18090870.
7. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000; 11. 408(6809):239–247. PMID:
11089981.
Article
8. Nagata M. Inflammatory cells and oxygen radicals. Curr Drug Targets Inflamm Allergy. 2005; 8. 4(4):503–504. PMID:
16101529.
Article
9. Babior BM. NADPH oxidase: an update. Blood. 1999; 3. 93(5):1464–1476. PMID:
10029572.
Article
10. Foley S, Navaratnam S, McGarvey DJ, Land EJ, Truscott TG, Rice-Evans CA. Singlet oxygen quenching and the redox properties of hydroxycinnamic acids. Free Radic Biol Med. 1999; 5. 26(9-10):1202–1208. PMID:
10381191.
Article
11. Kikuzaki H, Hisamoto M, Hirose K, Akiyama K, Taniguchi H. Antioxidant properties of ferulic acid and its related compounds. J Agric Food Chem. 2002; 3. 50(7):2161–2168. PMID:
11902973.
Article
12. Meyer AS, Frankel EN. Antioxidant activity of hydroxycinnamic acids on human low-density lipoprotein oxidation. Methods Enzymol. 2001; 335:256–265. PMID:
11400373.
Article
13. Park IH, Park SJ, Cho JS, Moon YM, Kim TH, Lee SH, et al. Role of reactive oxygen species in transforming growth factor beta1-induced alpha smooth-muscle actin and collagen production in nasal polyp-derived fibroblasts. Int Arch Allergy Immunol. 2012; 10. 159(3):278–286. PMID:
22722757.
Article
14. Marquez N, Sancho R, Macho A, Calzado MA, Fiebich BL, Munoz E. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors. J Pharmacol Exp Ther. 2004; 3. 308(3):993–1001. PMID:
14617683.
15. Liao HF, Chen YY, Liu JJ, Hsu ML, Shieh HJ, Liao HJ, et al. Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J Agric Food Chem. 2003; 12. 51(27):7907–7912. PMID:
14690372.
Article
16. Park HH, Park IH, Cho JS, Lee YM, Lee HM. The effect of macrolides on myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts. Am J Rhinol Allergy. 2010; Sep-Oct. 24(5):348–353. PMID:
21244734.
Article
17. Dagli M, Eryilmaz A, Besler T, Akmansu H, Acar A, Korkmaz H. Role of free radicals and antioxidants in nasal polyps. Laryngoscope. 2004; 7. 114(7):1200–1203. PMID:
15235348.
Article
18. Cheng YK, Tsai MH, Lin CD, Hwang GY, Hang LW, Tseng GC, et al. Oxidative stress in nonallergic nasal polyps associated with bronchial hyperresponsiveness. Allergy. 2006; 11. 61(11):1290–1298. PMID:
17002704.
Article